rs2274257

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003902.5(FUBP1):​c.1042-8C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0858 in 1,592,650 control chromosomes in the GnomAD database, including 7,084 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.091 ( 834 hom., cov: 32)
Exomes 𝑓: 0.085 ( 6250 hom. )

Consequence

FUBP1
NM_003902.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0001518
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0200

Publications

11 publications found
Variant links:
Genes affected
FUBP1 (HGNC:4004): (far upstream element binding protein 1) The protein encoded by this gene is a single stranded DNA-binding protein that binds to multiple DNA elements, including the far upstream element (FUSE) located upstream of c-myc. Binding to FUSE occurs on the non-coding strand, and is important to the regulation of c-myc in undifferentiated cells. This protein contains three domains, an amphipathic helix N-terminal domain, a DNA-binding central domain, and a C-terminal transactivation domain that contains three tyrosine-rich motifs. The N-terminal domain is thought to repress the activity of the C-terminal domain. This protein is also thought to bind RNA, and contains 3'-5' helicase activity with in vitro activity on both DNA-DNA and RNA-RNA duplexes. Aberrant expression of this gene has been found in malignant tissues, and this gene is important to neural system and lung development. Binding of this protein to viral RNA is thought to play a role in several viral diseases, including hepatitis C and hand, foot and mouth disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-77963723-G-C is Benign according to our data. Variant chr1-77963723-G-C is described in ClinVar as Benign. ClinVar VariationId is 402886.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FUBP1NM_003902.5 linkc.1042-8C>G splice_region_variant, intron_variant Intron 12 of 19 ENST00000370768.7 NP_003893.2 Q96AE4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FUBP1ENST00000370768.7 linkc.1042-8C>G splice_region_variant, intron_variant Intron 12 of 19 1 NM_003902.5 ENSP00000359804.2 Q96AE4-1

Frequencies

GnomAD3 genomes
AF:
0.0910
AC:
13835
AN:
152070
Hom.:
827
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0517
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.0927
Gnomad EAS
AF:
0.0862
Gnomad SAS
AF:
0.111
Gnomad FIN
AF:
0.171
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0798
Gnomad OTH
AF:
0.102
GnomAD2 exomes
AF:
0.115
AC:
26778
AN:
233514
AF XY:
0.112
show subpopulations
Gnomad AFR exome
AF:
0.0513
Gnomad AMR exome
AF:
0.249
Gnomad ASJ exome
AF:
0.0934
Gnomad EAS exome
AF:
0.0889
Gnomad FIN exome
AF:
0.155
Gnomad NFE exome
AF:
0.0827
Gnomad OTH exome
AF:
0.117
GnomAD4 exome
AF:
0.0853
AC:
122811
AN:
1440464
Hom.:
6250
Cov.:
28
AF XY:
0.0860
AC XY:
61627
AN XY:
716734
show subpopulations
African (AFR)
AF:
0.0498
AC:
1607
AN:
32238
American (AMR)
AF:
0.233
AC:
9322
AN:
39998
Ashkenazi Jewish (ASJ)
AF:
0.0898
AC:
2248
AN:
25028
East Asian (EAS)
AF:
0.0785
AC:
3099
AN:
39462
South Asian (SAS)
AF:
0.114
AC:
9448
AN:
82754
European-Finnish (FIN)
AF:
0.147
AC:
7828
AN:
53186
Middle Eastern (MID)
AF:
0.0809
AC:
458
AN:
5658
European-Non Finnish (NFE)
AF:
0.0757
AC:
83439
AN:
1102606
Other (OTH)
AF:
0.0901
AC:
5362
AN:
59534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
4764
9527
14291
19054
23818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3142
6284
9426
12568
15710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0911
AC:
13859
AN:
152186
Hom.:
834
Cov.:
32
AF XY:
0.0979
AC XY:
7283
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0517
AC:
2146
AN:
41538
American (AMR)
AF:
0.184
AC:
2808
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0927
AC:
321
AN:
3464
East Asian (EAS)
AF:
0.0862
AC:
447
AN:
5186
South Asian (SAS)
AF:
0.111
AC:
537
AN:
4826
European-Finnish (FIN)
AF:
0.171
AC:
1812
AN:
10584
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0798
AC:
5427
AN:
68010
Other (OTH)
AF:
0.102
AC:
216
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
638
1275
1913
2550
3188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0840
Hom.:
188
Bravo
AF:
0.0910
Asia WGS
AF:
0.121
AC:
418
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.64
DANN
Benign
0.52
PhyloP100
-0.020
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00015
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2274257; hg19: chr1-78429408; COSMIC: COSV53925539; API